BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29057288)

  • 41. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
    Kim CK; Park BK; Han JJ; Kang TW; Lee HM
    J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
    Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
    Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer.
    Dola EF; Nakhla OL; Genidi EA
    Eur J Radiol Open; 2017; 4():19-26. PubMed ID: 28377946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate zonal segmentation in 1.5T and 3T T2W MRI using a convolutional neural network.
    Jensen C; Sørensen KS; Jørgensen CK; Nielsen CW; Høy PC; Langkilde NC; Østergaard LR
    J Med Imaging (Bellingham); 2019 Jan; 6(1):014501. PubMed ID: 30820440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reference standard for the evaluation of automatic segmentation algorithms: Quantification of inter observer variability of manual delineation of prostate contour on MRI.
    Molière S; Hamzaoui D; Granger B; Montagne S; Allera A; Ezziane M; Luzurier A; Quint R; Kalai M; Ayache N; Delingette H; Renard-Penna R
    Diagn Interv Imaging; 2024 Feb; 105(2):65-73. PubMed ID: 37822196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1.
    Yang L; Li M; Zhang MN; Yao J; Song B
    Eur J Radiol; 2022 May; 150():110268. PubMed ID: 35344914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatic prostate and prostate zones segmentation of magnetic resonance images using DenseNet-like U-net.
    Aldoj N; Biavati F; Michallek F; Stober S; Dewey M
    Sci Rep; 2020 Aug; 10(1):14315. PubMed ID: 32868836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of dynamic contrast enhancement on diffusion weighted imaging score of 3 in prostate imaging reporting and data system version 2 of peripheral zone].
    Wang W; Shao ZH; Huang XH; Xu Y; Feng X; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1002-1006. PubMed ID: 32294857
    [No Abstract]   [Full Text] [Related]  

  • 50. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
    Zhang KS; Mayer P; Glemser PA; Tavakoli AA; Keymling M; Rotkopf LT; Meinzer C; Görtz M; Kauczor HU; Hielscher T; Stenzinger A; Bonekamp D; Hohenfellner M; Schlemmer HP
    Eur J Radiol; 2023 Oct; 167():111026. PubMed ID: 37639843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
    Song Y; Zhang YD; Yan X; Liu H; Zhou M; Hu B; Yang G
    J Magn Reson Imaging; 2018 Dec; 48(6):1570-1577. PubMed ID: 29659067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss.
    Xu Y; Klyuzhin I; Harsini S; Ortiz A; Zhang S; Bénard F; Dodhia R; Uribe CF; Rahmim A; Lavista Ferres J
    Comput Biol Med; 2023 May; 158():106882. PubMed ID: 37037147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatially varying accuracy and reproducibility of prostate segmentation in magnetic resonance images using manual and semiautomated methods.
    Shahedi M; Cool DW; Romagnoli C; Bauman GS; Bastian-Jordan M; Gibson E; Rodrigues G; Ahmad B; Lock M; Fenster A; Ward AD
    Med Phys; 2014 Nov; 41(11):113503. PubMed ID: 25370674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
    Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
    Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
    Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
    BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.